Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA373863
Max Phase: Preclinical
Molecular Formula: C11H11ClN2O2
Molecular Weight: 238.67
Molecule Type: Small molecule
Associated Items:
ID: ALA373863
Max Phase: Preclinical
Molecular Formula: C11H11ClN2O2
Molecular Weight: 238.67
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CNO)Cc1c[nH]c2ccc(Cl)cc12
Standard InChI: InChI=1S/C11H11ClN2O2/c12-8-1-2-11-10(4-8)7(5-13-11)3-9(15)6-14-16/h1-2,4-5,13-14,16H,3,6H2
Standard InChI Key: MYXKSLVPRCMZIE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 238.67 | Molecular Weight (Monoisotopic): 238.0509 | AlogP: 1.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 65.12 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.87 | CX LogP: 1.83 | CX LogD: 1.83 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.71 | Np Likeness Score: -0.47 |
1. Boularot A, Giglione C, Petit S, Duroc Y, Alves de Sousa R, Larue V, Cresteil T, Dardel F, Artaud I, Meinnel T.. (2007) Discovery and refinement of a new structural class of potent peptide deformylase inhibitors., 50 (1): [PMID:17201406] [10.1021/jm060910c] |
Source(1):